Five-Layer Islet Encapsulation for Immune Protection and Glucose Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing pancreatic islet transplantation methods require strong immunosuppression due to immune rejection, which has side effects, and encapsulation methods have not achieved sufficient therapeutic results.

Innovation Solution

A five-layered membrane formulation comprising alginic acid and polyornithine layers around pancreatic islets to protect them from immune attack, maintaining blood glucose levels effectively.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If pancreatic islets are transplanted without encapsulation, then immune rejection occurs requiring strong immunosuppression, but this causes side effects from immunosuppressant administration

Engineering Contradiction:
Improvelong-term survival of transplanted pancreatic isletsVSAvoidside effects of immunosuppressants
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The encapsulation membrane is divided into five distinct layers with alternating materials (alginic acid and polyornithine), creating a segmented structure that provides different functional properties at each layer to simultaneously achieve immunoprotection and nutrient permeability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses composite materials combining alginic acid and polyornithine in a five-layered alternating structure, leveraging the complementary properties of these materials to create a membrane that is both immunoprotective and permeable to necessary substances

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If microcapsulation is used to isolate pancreatic islets from immune cells, then immunosuppression is not required, but sufficient therapeutic results have not been obtained

Engineering Contradiction:
Improveimmune rejectionVSAvoidtherapeutic results
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

Different layers of the encapsulation membrane have different local qualities - alginic acid layers provide immunoprotection while polyornithine layers enhance permeability and promote islet survival, creating localized functional zones within the membrane structure

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The membrane structure incorporates porous characteristics that allow selective permeability to nutrients, waste products, and insulin while blocking immune cells, achieving both protection and therapeutic effectiveness

Inventive Principle:
Principle #31Porous materials

3Ease of manufacture

If a simple encapsulation structure is used, then manufacturing is easier, but immune protection and therapeutic effectiveness are insufficient

Engineering Contradiction:
Improveencapsulation process simplicityVSAvoidimmune protection effectiveness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The five-layered membrane is constructed through sequential deposition steps that, while multiple, use standardized procedures for each layer, making the segmented structure manufacturable through repetitive, controlled processes

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention optimizes specific parameters such as layer thickness, material concentration, and deposition conditions to achieve the desired balance between manufacturing feasibility and immune protection effectiveness

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The five-layered membrane formulation significantly prolongs the maintenance of appropriate blood glucose levels and reduces fibrosis, providing an effective treatment for diabetes without the need for immunosuppression.

Implementation Method 1

the first, third, and fifth membranes from the inner side of the five-layered membrane contain alginic acid, and the second and fourth membranes from the inner side contain polyornithine

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Data Source

PatentEP4169519B1Encapsulated pancreatic islet
Publication Date: 2025.11.12 OTSUKA PHARMACEUTICAL FACTORY INC
  • EP4169519B1 patent drawingFigure 1~2

AI summary

[Object] The present invention provides an improved encapsulated pancreatic islet. [Method for Achieving the Object] A formulation comprising a core covered with a five-layered membrane, wherein the core comprises one or more pancreatic islets; and the first, third, and fifth membranes from the inner side of the five-layered membrane contain alginic acid, and the second and fourth membranes from the inner side contain polyornithine.